CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma

BACKGROUND: The development of drug resistance leads many NPC patients to experience disease relapse following the completion of chemotherapy. It is thus essential that the mechanistic basis for such chemoresistance be clarified in an effort to identify approaches to sensitizing NPC tumors to treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Junwu, Qin, Hong, Han, Yue, Li, Xinghua, Zhao, YuJuan, Zhai, Guangsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850406/
https://www.ncbi.nlm.nih.gov/pubmed/33536745
http://dx.doi.org/10.2147/DDDT.S292180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850406/
https://www.ncbi.nlm.nih.gov/pubmed/33536745
http://dx.doi.org/10.2147/DDDT.S292180

Ejemplares similares